Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects

NCT03402178 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

118

Enrollment

INDUSTRY

Sponsor class

Stopped Safety Review

Conditions

Healthy Participants

Interventions

DRUG: E2082
DRUG: Placebo

Sponsor

Eisai Co., Ltd.